A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study

Author： Rose P.G. Rodriguez M. Walker J. Greer B. Fusco N. McGuire W.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.1, 2002-04, pp. : 136-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Lewandowski G.S. Creasman W.T. Webster K.D.

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite

Prolonged Oral Etoposide in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Van Le L. Waggoner S.

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 263-266

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Thigpen T. Blessing J.A. Yordan E. Valea F. Vaccarello L.

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 120-122

Academic Press

Access to resources Recommend Favorite

Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Retrospective Comparative Study of Single-Agent Dosages

By Rose P.G. Hawthorne Maxson J. Fusco N. Mossbruger K. Rodriguez M.

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 323-328

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of CI-958 in Recurrent Platinum-Sensitive Ovarian Carcinoma: A Gynecologic Oncology Group Study

By Hoffman M.A. Blessing J.A. Nunez E.R.

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 433-435

Elsevier

Access to resources Recommend Favorite